g. VEGF suppression), administrated at divergent doses or with the same dose in distinct tumor types, is able to harness vessel repression and further aggravate hypoxia or vascular normalization, and thereby reoxygenation in tumors (143, 144). This evidence concerns the gene VEGFA and neoplasm.